| Stage | MDT | % of rev | BLFS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.8B | 100.00% | $28M | 100.00% | MDT ×342.72 |
| Gross profit | $6.3B | 64.99% | $18M | 64.24% | MDT +0.7pp |
| Operating income | $1.8B | 18.08% | $2M | 5.96% | MDT +12.1pp |
| Pre-tax income | $1.8B | 18.13% | $3M | 9.67% | MDT +8.5pp |
| Net income | $1.5B | 15.16% | $45M | 158.45% | BLFS +143.3pp |
| Stage | MDT | BLFS | Gap · A − B |
|---|---|---|---|
| Revenue | $9.8B100.00% | $28M100.00% | MDT ×342.72 |
| Gross profit | 64.99%$6.3B | 64.24%$18M | MDT +0.7pp |
| Operating income | 18.08%$1.8B | 5.96%$2M | MDT +12.1pp |
| Pre-tax income | 18.13%$1.8B | 9.67%$3M | MDT +8.5pp |
| Net income |
| 15.16%$1.5B |
| 158.45%$45M |
| BLFS +143.3pp |
No disclosed counterparties: BLFS.
None